Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ali T et al. – To provide a comprehensive review regarding the concerns of long–term PPI use, a literature search was performed to identify pertinent original and review articles. Despite study shortcomings, the collective body of information overwhelmingly suggests an increased risk of infectious complications and nutritional deficiencies. Data regarding any increased risk in gastric or colon malignancy are less convincing. PPIs have revolutionized the management and complications of acid–related disorders with a high margin of safety; however, with the data available, efforts to reduce the dosing of or discontinue the use of PPIs must be reassessed frequently.

Related Articles

Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09    Relevance Score: 88%

Novartis launches Prevacid24HR over-the-counter for full 24-hour frequent heartburn treatment
Novartis, 11/13/09    Relevance Score: 87%

How Safe Are Popular Reflux Drugs?
MedLinePlus, 11/06/09    Relevance Score: 87%

Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill'
Internet Source, 10/30/09    Relevance Score: 87%

XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09    Relevance Score: 87%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address